Higher blood levels of the glial fibrillary acidic protein (GFAP) are significantly associated with shrinkage in certain brain regions of people with neuromyelitis optica spectrum disorder (NMOSD) who have antibodies against the AQP4 protein, a study showed. This association was not observed in people with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), a related condition, further emphasizing […] The post Blood GFAP may be biomarker of brain shrinkage in AQP4-NMOS...
